低密度脂蛋白受体基因型是纯合子家族性高胆固醇血症患者进行脂蛋白分离术后低密度脂蛋白胆固醇浓度反弹的重要决定因素。 - Suppr

The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia.

作者信息

Drouin-Chartier Jean-Philippe, Tremblay André J, Bergeron Jean, Lamarche Benoît, Couture Patrick

机构信息

From Institute on Nutrition and Functional Foods, Université Laval, Quebec City, Quebec, Canada (J.-P.D.-C., A.J.T., B.L., P.C.); and Centre Hospitalier Universitaire de Québec Research Center, Université Laval, Quebec City, Canada (J.B., P.C.).

出版信息

Circulation. 2017 Aug 29;136(9):880-882. doi: 10.1161/CIRCULATIONAHA.117.029435.

DOI:10.1161/CIRCULATIONAHA.117.029435

PMID:28847800

Abstract

摘要

相似文献

The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia.低密度脂蛋白受体基因型是纯合子家族性高胆固醇血症患者进行脂蛋白分离术后低密度脂蛋白胆固醇浓度反弹的重要决定因素。

Circulation. 2017 Aug 29;136(9):880-882. doi: 10.1161/CIRCULATIONAHA.117.029435.

High serum triglyceride concentrations in patients with homozygous familial hypercholesterolemia attenuate the efficacy of lipoprotein apheresis by dextran sulfate adsorption.载脂蛋白 B 代谢研究进展

Atherosclerosis. 2018 Mar;270:26-32. doi: 10.1016/j.atherosclerosis.2018.01.005. Epub 2018 Jan 12.

Pregnancy in homozygous familial hypercholesterolemia--Importance of LDL-apheresis.纯合子家族性高胆固醇血症患者的妊娠——低密度脂蛋白去除法的重要性

Atheroscler Suppl. 2015 May;18:134-9. doi: 10.1016/j.atherosclerosissup.2015.02.024.

A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry).土耳其接受 LDL 吸附治疗的纯合子家族性高胆固醇血症患者的全国性调查（A-HIT 1 注册研究）。

Atherosclerosis. 2018 Mar;270:42-48. doi: 10.1016/j.atherosclerosis.2018.01.034. Epub 2018 Jan 31.

The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial.洛美他派的降脂作用不受纯合子家族性高胆固醇血症患者辅助性血液成分单采的影响——一项3期单臂开放标签试验的事后分析

Atherosclerosis. 2015 Jun;240(2):408-14. doi: 10.1016/j.atherosclerosis.2015.03.014. Epub 2015 Mar 14.

How can we improve the prognosis of patients with homozygous familial hypercholesterolemia?我们如何改善纯合子家族性高胆固醇血症患者的预后？

Atherosclerosis. 2024 Jun;393:117551. doi: 10.1016/j.atherosclerosis.2024.117551. Epub 2024 Apr 16.

First case report of familial hypercholesterolemia in an Omani family due to novel mutation in the low-density lipoprotein receptor gene.首例因低密度脂蛋白受体基因突变导致的阿曼家族性高胆固醇血症病例报告。

Angiology. 2013 May;64(4):287-92. doi: 10.1177/0003319712465171. Epub 2012 Nov 15.

Disease control via intensified lipoprotein apheresis in three siblings with familial hypercholesterolemia.通过强化脂蛋白分离术对三名家族性高胆固醇血症患者进行疾病控制。

J Clin Lipidol. 2016 Nov-Dec;10(6):1303-1310. doi: 10.1016/j.jacl.2016.08.006. Epub 2016 Aug 20.

Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France.法国某单一中心 53 例纯合子家族性高胆固醇血症患者的长期预后。

Atherosclerosis. 2017 Feb;257:130-137. doi: 10.1016/j.atherosclerosis.2017.01.015. Epub 2017 Jan 16.

Managing homozygous familial hypercholesterolaemia from cradle to grave.从摇篮到坟墓管理纯合子家族性高胆固醇血症。

Atheroscler Suppl. 2015 May;18:16-20. doi: 10.1016/j.atherosclerosissup.2015.02.002.

引用本文的文献

Treatment of Homozygous Familial Hypercholesterolemia.纯合子家族性高胆固醇血症的治疗

JACC Adv. 2025 Apr 26;4(5):101708. doi: 10.1016/j.jacadv.2025.101708.

Low-density lipoprotein receptor genotypes modify the sera metabolome of patients with homozygous familial hypercholesterolemia.低密度脂蛋白受体基因型可改变纯合子家族性高胆固醇血症患者的血清代谢组。

iScience. 2022 Oct 12;25(11):105334. doi: 10.1016/j.isci.2022.105334. eCollection 2022 Nov 18.

Correlates of Coronary Artery Calcification Prevalence and Severity in Patients With Heterozygous Familial Hypercholesterolemia.杂合子家族性高胆固醇血症患者冠状动脉钙化患病率及严重程度的相关因素

CJC Open. 2020 Sep 16;3(1):62-70. doi: 10.1016/j.cjco.2020.09.010. eCollection 2021 Jan.

Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care.家族性高胆固醇血症：设计适应性护理模式的知识演进。

Nat Rev Cardiol. 2020 Jun;17(6):360-377. doi: 10.1038/s41569-019-0325-8. Epub 2020 Jan 23.

Improvement of oxidative stress status by lipoprotein apheresis in Chinese patients with familial hypercholesterolemia.脂蛋白吸附术改善中国家族性高胆固醇血症患者的氧化应激状态。

J Clin Lab Anal. 2020 May;34(5):e23161. doi: 10.1002/jcla.23161. Epub 2019 Dec 20.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia.

作者信息

Drouin-Chartier Jean-Philippe, Tremblay André J, Bergeron Jean, Lamarche Benoît, Couture Patrick

机构信息

出版信息

Circulation. 2017 Aug 29;136(9):880-882. doi: 10.1161/CIRCULATIONAHA.117.029435.

DOI:10.1161/CIRCULATIONAHA.117.029435

PMID:28847800

Abstract

摘要

The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia.

作者信息

机构信息

出版信息

相似文献

引用本文的文献